Marketing-authorisation holder · Singapore
Nyprax Pharma Pte. Ltd.
2 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
2 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL100.0 mg/vial · Injection, powder, lyophilized, for solution | Thiotepa | Singapore | Authorised | 2024 |
| THIOTEPA RIEMSER POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 15MG/VIAL15.0 mg/vial · Injection, powder, lyophilized, for solution | Thiotepa | Singapore | Authorised | 2024 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 2 | 2 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antineoplastic agentsAntineoplastic and immunomodulating agents · ATC L01A